March 4, 2020
Shionogi’s siderophore cephalosporin Fetcroja (cefiderocol) has obtained the backing of a key European advisory panel for the treatment of Gram-negative bacteria infections in adults, the Osaka-based drug maker said on March 3. The European Medicines Agency’s (EMA) Committee for Medicinal...read more